Skip to main
CTRE
CTRE logo

CareTrust REIT (CTRE) Stock Forecast & Price Target

CareTrust REIT (CTRE) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 28%
Buy 39%
Hold 28%
Sell 6%
Strong Sell 0%

Bulls say

CareTrust REIT is positioned for substantial growth, with an expected increase in estimated net asset value (NAV) per share from $21.62 to $24.05 between the end of 2024 and the end of 2025. The company is nearing completion of its portfolio optimization plan, which has led to a recovering core portfolio and better management of tenant credit concerns, facilitating more aggressive and accretive capital deployment. Additionally, the recent $817 million acquisition of UK-based Care REIT is anticipated to enhance enterprise value and provide modest organic growth, further reinforcing CareTrust REIT's favorable outlook in the current competitive investment landscape.

Bears say

CareTrust REIT faces a challenging financial outlook due to projected slower cash collections, estimated to decline by approximately 5%, alongside reduced investment activity predicted at around $500 million. The potential impact of the CA 525 bill raises concerns about operators' profitability in California, which could further pressure CareTrust's rental income. Additionally, ongoing issues with new tenants, compounded by Medicaid cuts and persistent reimbursement challenges, threaten the company's ability to maintain earnings growth, contributing to a generally negative sentiment surrounding the stock.

CareTrust REIT (CTRE) has been analyzed by 18 analysts, with a consensus rating of Buy. 28% of analysts recommend a Strong Buy, 39% recommend Buy, 28% suggest Holding, 6% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of CareTrust REIT and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About CareTrust REIT (CTRE) Forecast

Analysts have given CareTrust REIT (CTRE) a Buy based on their latest research and market trends.

According to 18 analysts, CareTrust REIT (CTRE) has a Buy consensus rating as of Jul 3, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $23.78, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $23.78, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

CareTrust REIT (CTRE)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.